Latest Statin Stories
This study’s publication comes as hundreds of Lipitor lawsuit plaintiffs seek compensation for Type 2 diabetes they allegedly developed due to their use of the cholesterol-lowering statin.
The Webinar on December 9, 2014 will focus on testing for antibodies found in autoimmune myopathy patients Yorba Linda, CA (PRWEB) December 04, 2014
Novel Emerging Therapies Are Expected to Reinvigorate a Market Constrained By Patent Expirations of Leading Treatments, According to Findings from Decision Resources Group BURLINGTON, Mass.,
The Firm is investigating allegations that the use of Lipitor may increase a patient’s risk of developing Type 2 diabetes. New York, New York (PRWEB) November
Lipitor lawsuits claim that the statin medication increases the risk that a patient will develop Type 2 diabetes. New York, New York (PRWEB) November 22, 2014
The Firm is evaluating Lipitor lawsuits on behalf of patients who developed Type 2 diabetes, allegedly due to their use of the statin medication. New York, New
Additional Data Analysis Showed Every Two Week and Monthly Dosing Regimens of Evolocumab Were Clinically Equivalent THOUSAND OAKS, Calif., Nov.
The Heart Attack Eradication Society Urges Doctors to Adopt Personalized Risk Assessment. Houston, TX (PRWEB) November 12, 2014 Leading preventive cardiologists
Thirteen Presentations Include New Analyses of PCSK9 Inhibitor at Upcoming American Heart Association Scientific Sessions THOUSAND OAKS, Calif., Nov.
THOUSAND OAKS, Calif., Nov. 10, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the U.S.
- A volcanic mudflow.